The CHDS Cervical Cancer Team presented new research results at the 32nd International Papillomavirus Conference in Sydney, Australia. Principal Investigator and CHDS core faculty Jane Kim presented comparative modeling results from the CISNET consortium that highlighted the benefits, harms, and cost-effectiveness of primary HPV screening in the US. This work provides critical evidence for policy makers developing or assessing cervical cancer screening guidelines. Dr. Kim also presented the benefits of single-dose HPV vaccination in Gavi-eligible countries, the evolution of cervical cancer screening recommendations in the US, and the role of modeling in these guidelines.
Other team members presented additional results:
Nicole Campos discussed the cost-effectiveness of cervical cancer screening for women living with HIV in South Africa, the health impact of delayed implementation of cervical cancer screening in India, and the cost-effectiveness of integrating cervical cancer and treatment in HIV care clinics in Kenya.
Stephen Sy presented the time-varying cost-effectiveness of HPV vaccination in low- and middle-income countries.
Allison Portnoy and Jamie Cohen presented their graduate research on the impact and cost-effectiveness of human papillomavirus (HPV) vaccination campaigns and the value of HIV testing for cervical cancer screening, respectively.
Learn more: Read about cervical cancer models in a CHDS resource pack here.